Haas S - Search Results

1

Anticoagulation: the present and future.

Van Aken H, Bode C, Darius H, Diehm C, Encke A, Gulba DC, Haas S, Hacke W, Puhl W, Quante M, Riess H, Scharf R, Schellong S, Schrör T, Schulte KL, Tebbe U. Van Aken H, et al. Among authors: haas s. Clin Appl Thromb Hemost. 2001 Jul;7(3):195-204. doi: 10.1177/107602960100700303. Clin Appl Thromb Hemost. 2001. PMID: 11441979 Free article. Review.

2

Benefits and risks of preventing thromboembolism with enoxaparin in patients with general surgery in real world--the CLEVER study.

Schellong SM, Encke A, Weber AA, Bramlage P, Paar WD, Haas S. Schellong SM, et al. Among authors: haas s. Clin Appl Thromb Hemost. 2013 Jun;19(3):282-8. doi: 10.1177/1076029612461067. Epub 2012 Oct 11. Clin Appl Thromb Hemost. 2013. PMID: 23064219 Free article.

3

[Bridging anticoagulation].

Schellong SM, Halbritter K, Haas S. Schellong SM, et al. Among authors: haas s. Chirurg. 2007 Feb;78(2):125-6, 128-32. doi: 10.1007/s00104-006-1290-4. Chirurg. 2007. PMID: 17252252 Review. German.

4

New anticoagulants: from bench to bedside.

Haas S, Schellong S. Haas S, et al. Hamostaseologie. 2007 Feb;27(1):41-7. Hamostaseologie. 2007. PMID: 17279275 Review.

5

CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, Sieder C, Melzer N, Bramlage P, Riess H. Bauersachs R, et al. Among authors: haas s. Thromb Haemost. 2011 Jun;105(6):981-8. doi: 10.1160/TH10-09-0614. Epub 2011 Apr 20. Thromb Haemost. 2011. PMID: 21505722 Clinical Trial.

6

Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.

Haas S, Wolf H, Kakkar AK, Fareed J, Encke A. Haas S, et al. Thromb Haemost. 2005 Oct;94(4):814-9. doi: 10.1160/TH02-10-0189. Thromb Haemost. 2005. PMID: 16270636 Clinical Trial.

7

Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY.

Haas S, Schellong SM, Tebbe U, Gerlach HE, Bauersachs R, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H. Haas S, et al. BMC Cancer. 2011 Jul 26;11:316. doi: 10.1186/1471-2407-11-316. BMC Cancer. 2011. PMID: 21791091 Free PMC article. Clinical Trial.

8

[Home treatment for deep vein thrombosis: pros and cons].

Bauersachs R, Haas S, Schellong S. Bauersachs R, et al. Among authors: haas s. Hamostaseologie. 2004 Aug;24(3):167-72. doi: 10.1267/hamo04030167. Hamostaseologie. 2004. PMID: 15314701 Review. German.

9

[Preventing venous thromboembolism].

Encke A, Haas S. Encke A, et al. Among authors: haas s. Chirurg. 2007 Feb;78(2):110, 112-8. doi: 10.1007/s00104-006-1295-z. Chirurg. 2007. PMID: 17265054 Review. German.

10

Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY study.

Schellong SM, Gerlach HE, Tebbe U, Haas S, Melzer N, Abletshauser C, Sieder C, Bramlage P, Riess H, Bauersachs R. Schellong SM, et al. Among authors: haas s. Thromb Res. 2011 Nov;128(5):417-21. doi: 10.1016/j.thromres.2011.05.002. Epub 2011 Jun 11. Thromb Res. 2011. PMID: 21658750 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,434 results

Search Page